These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34998430)

  • 1. Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases.
    Huang F; Thokerunga E; He F; Zhu X; Wang Z; Tu J
    Stem Cell Res Ther; 2022 Jan; 13(1):1. PubMed ID: 34998430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stem/Stromal Cell-Based Therapies in Systemic Rheumatic Disease: From Challenges to New Approaches for Overcoming Restrictions.
    Lee BW; Kwok SK
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases.
    Jasim SA; Yumashev AV; Abdelbasset WK; Margiana R; Markov A; Suksatan W; Pineda B; Thangavelu L; Ahmadi SH
    Stem Cell Res Ther; 2022 Mar; 13(1):101. PubMed ID: 35255979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
    Xu J
    Adv Exp Med Biol; 2018; 1089():73-85. PubMed ID: 29767288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells transplantation for systemic lupus erythematosus.
    Liang J; Sun L
    Int J Rheum Dis; 2015 Feb; 18(2):164-71. PubMed ID: 25611801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.
    Zhang H; Zeng X; Sun L
    Expert Opin Biol Ther; 2010 May; 10(5):701-9. PubMed ID: 20345339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.
    Zhu Y; Feng X
    Stem Cell Res Ther; 2018 May; 9(1):149. PubMed ID: 29793537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mesenchymal stem cell treatment in autoimmune diseases].
    Keyßer G
    Z Rheumatol; 2020 Jun; 79(5):437-445. PubMed ID: 32322976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.
    Wang D; Wang S; Huang S; Zhang Z; Yuan X; Feng X; Lu L; Sun L
    Stem Cells Transl Med; 2017 Sep; 6(9):1777-1785. PubMed ID: 28755405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus.
    Tang WY; Liu JH; Peng CJ; Liao Y; Luo JS; Sun X; Tang YL; Luo XQ
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):7. PubMed ID: 33713197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
    Liu S; Guo YL; Yang JY; Wang W; Xu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
    Xie Q; Liu R; Jiang J; Peng J; Yang C; Zhang W; Wang S; Song J
    Stem Cell Res Ther; 2020 Dec; 11(1):519. PubMed ID: 33261658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
    Li A; Guo F; Pan Q; Chen S; Chen J; Liu HF; Pan Q
    Front Immunol; 2021; 12():728190. PubMed ID: 34659214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells transplantation in systemic lupus erythematosus treatment.
    Huang X; Xu M; Li L; Zeng K
    Dermatol Ther; 2020 Nov; 33(6):e14262. PubMed ID: 32869914
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases.
    Hua C; Chen S; Cheng H
    Hum Vaccin Immunother; 2022 Nov; 18(6):2144667. PubMed ID: 36382475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus.
    Zheng B; Zhang P; Yuan L; Chhetri RK; Guo Y; Deng D
    Lupus; 2020 Feb; 29(2):126-135. PubMed ID: 31870216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells.
    Terraza-Aguirre C; Campos-Mora M; Elizondo-Vega R; Contreras-López RA; Luz-Crawford P; Jorgensen C; Djouad F
    Cells; 2020 Jul; 9(7):. PubMed ID: 32664207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
    Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
    Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges.
    Peltzer J; Aletti M; Frescaline N; Busson E; Lataillade JJ; Martinaud C
    Front Immunol; 2018; 9():2013. PubMed ID: 30271402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.